nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—Platelet count decreased—Entecavir—hepatitis B	0.0358	0.0358	CcSEcCtD
Palonosetron—Glycosuria—Entecavir—hepatitis B	0.0263	0.0263	CcSEcCtD
Palonosetron—Glycosuria—Adefovir Dipivoxil—hepatitis B	0.0257	0.0257	CcSEcCtD
Palonosetron—Hyperkalaemia—Adefovir Dipivoxil—hepatitis B	0.0204	0.0204	CcSEcCtD
Palonosetron—Influenza like illness—Telbivudine—hepatitis B	0.017	0.017	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Entecavir—hepatitis B	0.016	0.016	CcSEcCtD
Palonosetron—Hypoxia—Lamivudine—hepatitis B	0.0155	0.0155	CcSEcCtD
Palonosetron—Abdominal pain upper—Entecavir—hepatitis B	0.0141	0.0141	CcSEcCtD
Palonosetron—Amblyopia—Lamivudine—hepatitis B	0.0128	0.0128	CcSEcCtD
Palonosetron—Pain in extremity—Telbivudine—hepatitis B	0.0127	0.0127	CcSEcCtD
Palonosetron—Hyperglycaemia—Entecavir—hepatitis B	0.0121	0.0121	CcSEcCtD
Palonosetron—Abdominal pain upper—Telbivudine—hepatitis B	0.0116	0.0116	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0114	0.0114	CcSEcCtD
Palonosetron—Hepatobiliary disease—Entecavir—hepatitis B	0.0113	0.0113	CcSEcCtD
Palonosetron—Gastritis—Telbivudine—hepatitis B	0.0112	0.0112	CcSEcCtD
Palonosetron—Abdominal distension—Telbivudine—hepatitis B	0.0111	0.0111	CcSEcCtD
Palonosetron—Hepatobiliary disease—Adefovir Dipivoxil—hepatitis B	0.011	0.011	CcSEcCtD
Palonosetron—Sinusitis—Adefovir Dipivoxil—hepatitis B	0.0109	0.0109	CcSEcCtD
Palonosetron—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Palonosetron—Connective tissue disorder—Adefovir Dipivoxil—hepatitis B	0.0103	0.0103	CcSEcCtD
Palonosetron—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0102	0.0102	CcSEcCtD
Palonosetron—Immune system disorder—Entecavir—hepatitis B	0.00967	0.00967	CcSEcCtD
Palonosetron—Alopecia—Entecavir—hepatitis B	0.00946	0.00946	CcSEcCtD
Palonosetron—Mental disorder—Entecavir—hepatitis B	0.00938	0.00938	CcSEcCtD
Palonosetron—Malnutrition—Entecavir—hepatitis B	0.00932	0.00932	CcSEcCtD
Palonosetron—Hepatobiliary disease—Telbivudine—hepatitis B	0.00926	0.00926	CcSEcCtD
Palonosetron—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00909	0.00909	CcSEcCtD
Palonosetron—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00896	0.00896	CcSEcCtD
Palonosetron—Connective tissue disorder—Telbivudine—hepatitis B	0.00864	0.00864	CcSEcCtD
Palonosetron—Anaemia—Adefovir Dipivoxil—hepatitis B	0.0084	0.0084	CcSEcCtD
Palonosetron—Mediastinal disorder—Telbivudine—hepatitis B	0.00793	0.00793	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00788	0.00788	CcSEcCtD
Palonosetron—Myalgia—Adefovir Dipivoxil—hepatitis B	0.00774	0.00774	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00769	0.00769	CcSEcCtD
Palonosetron—Malnutrition—Telbivudine—hepatitis B	0.00766	0.00766	CcSEcCtD
Palonosetron—Anaphylactic shock—Entecavir—hepatitis B	0.00761	0.00761	CcSEcCtD
Palonosetron—Infection—Entecavir—hepatitis B	0.00756	0.00756	CcSEcCtD
Palonosetron—Dysgeusia—Telbivudine—hepatitis B	0.0075	0.0075	CcSEcCtD
Palonosetron—Nervous system disorder—Entecavir—hepatitis B	0.00746	0.00746	CcSEcCtD
Palonosetron—Skin disorder—Entecavir—hepatitis B	0.00739	0.00739	CcSEcCtD
Palonosetron—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00728	0.00728	CcSEcCtD
Palonosetron—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00721	0.00721	CcSEcCtD
Palonosetron—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00707	0.00707	CcSEcCtD
Palonosetron—Insomnia—Entecavir—hepatitis B	0.00688	0.00688	CcSEcCtD
Palonosetron—Somnolence—Entecavir—hepatitis B	0.00676	0.00676	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Adefovir Dipivoxil—hepatitis B	0.00676	0.00676	CcSEcCtD
Palonosetron—Dyspepsia—Entecavir—hepatitis B	0.00669	0.00669	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Entecavir—hepatitis B	0.00657	0.00657	CcSEcCtD
Palonosetron—Fatigue—Entecavir—hepatitis B	0.00656	0.00656	CcSEcCtD
Palonosetron—Abdominal pain upper—Lamivudine—hepatitis B	0.00654	0.00654	CcSEcCtD
Palonosetron—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00653	0.00653	CcSEcCtD
Palonosetron—Arthralgia—Telbivudine—hepatitis B	0.00652	0.00652	CcSEcCtD
Palonosetron—Myalgia—Telbivudine—hepatitis B	0.00652	0.00652	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00647	0.00647	CcSEcCtD
Palonosetron—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00645	0.00645	CcSEcCtD
Palonosetron—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00645	0.00645	CcSEcCtD
Palonosetron—Discomfort—Telbivudine—hepatitis B	0.00644	0.00644	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00641	0.00641	CcSEcCtD
Palonosetron—Abdominal distension—Lamivudine—hepatitis B	0.00623	0.00623	CcSEcCtD
Palonosetron—Gastrointestinal pain—Entecavir—hepatitis B	0.00622	0.00622	CcSEcCtD
Palonosetron—Nervous system disorder—Telbivudine—hepatitis B	0.00613	0.00613	CcSEcCtD
Palonosetron—Skin disorder—Telbivudine—hepatitis B	0.00607	0.00607	CcSEcCtD
Palonosetron—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00607	0.00607	CcSEcCtD
Palonosetron—Body temperature increased—Entecavir—hepatitis B	0.00601	0.00601	CcSEcCtD
Palonosetron—Abdominal pain—Entecavir—hepatitis B	0.00601	0.00601	CcSEcCtD
Palonosetron—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00587	0.00587	CcSEcCtD
Palonosetron—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00587	0.00587	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Telbivudine—hepatitis B	0.00569	0.00569	CcSEcCtD
Palonosetron—Insomnia—Telbivudine—hepatitis B	0.00565	0.00565	CcSEcCtD
Palonosetron—Paraesthesia—Telbivudine—hepatitis B	0.00561	0.00561	CcSEcCtD
Palonosetron—Hyperglycaemia—Lamivudine—hepatitis B	0.00559	0.00559	CcSEcCtD
Palonosetron—Dyspepsia—Telbivudine—hepatitis B	0.0055	0.0055	CcSEcCtD
Palonosetron—Asthenia—Entecavir—hepatitis B	0.00546	0.00546	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00539	0.00539	CcSEcCtD
Palonosetron—Fatigue—Telbivudine—hepatitis B	0.00539	0.00539	CcSEcCtD
Palonosetron—Pain—Telbivudine—hepatitis B	0.00534	0.00534	CcSEcCtD
Palonosetron—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00532	0.00532	CcSEcCtD
Palonosetron—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00525	0.00525	CcSEcCtD
Palonosetron—Hepatobiliary disease—Lamivudine—hepatitis B	0.00522	0.00522	CcSEcCtD
Palonosetron—Epistaxis—Lamivudine—hepatitis B	0.00521	0.00521	CcSEcCtD
Palonosetron—Diarrhoea—Entecavir—hepatitis B	0.0052	0.0052	CcSEcCtD
Palonosetron—Sinusitis—Lamivudine—hepatitis B	0.00518	0.00518	CcSEcCtD
Palonosetron—Gastrointestinal pain—Telbivudine—hepatitis B	0.00511	0.00511	CcSEcCtD
Palonosetron—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00508	0.00508	CcSEcCtD
Palonosetron—Dizziness—Entecavir—hepatitis B	0.00503	0.00503	CcSEcCtD
Palonosetron—Abdominal pain—Telbivudine—hepatitis B	0.00494	0.00494	CcSEcCtD
Palonosetron—Body temperature increased—Telbivudine—hepatitis B	0.00494	0.00494	CcSEcCtD
Palonosetron—Connective tissue disorder—Lamivudine—hepatitis B	0.00487	0.00487	CcSEcCtD
Palonosetron—Vomiting—Entecavir—hepatitis B	0.00484	0.00484	CcSEcCtD
Palonosetron—Rash—Entecavir—hepatitis B	0.0048	0.0048	CcSEcCtD
Palonosetron—Dermatitis—Entecavir—hepatitis B	0.00479	0.00479	CcSEcCtD
Palonosetron—Headache—Entecavir—hepatitis B	0.00476	0.00476	CcSEcCtD
Palonosetron—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00472	0.00472	CcSEcCtD
Palonosetron—Rash—Adefovir Dipivoxil—hepatitis B	0.00468	0.00468	CcSEcCtD
Palonosetron—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00467	0.00467	CcSEcCtD
Palonosetron—Headache—Adefovir Dipivoxil—hepatitis B	0.00465	0.00465	CcSEcCtD
Palonosetron—Nausea—Entecavir—hepatitis B	0.00452	0.00452	CcSEcCtD
Palonosetron—Asthenia—Telbivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Palonosetron—Immune system disorder—Lamivudine—hepatitis B	0.00448	0.00448	CcSEcCtD
Palonosetron—Mediastinal disorder—Lamivudine—hepatitis B	0.00447	0.00447	CcSEcCtD
Palonosetron—Chills—Lamivudine—hepatitis B	0.00445	0.00445	CcSEcCtD
Palonosetron—Pruritus—Telbivudine—hepatitis B	0.00442	0.00442	CcSEcCtD
Palonosetron—Nausea—Adefovir Dipivoxil—hepatitis B	0.00441	0.00441	CcSEcCtD
Palonosetron—Alopecia—Lamivudine—hepatitis B	0.00438	0.00438	CcSEcCtD
Palonosetron—Erythema—Lamivudine—hepatitis B	0.00431	0.00431	CcSEcCtD
Palonosetron—Malnutrition—Lamivudine—hepatitis B	0.00431	0.00431	CcSEcCtD
Palonosetron—Diarrhoea—Telbivudine—hepatitis B	0.00427	0.00427	CcSEcCtD
Palonosetron—Flatulence—Lamivudine—hepatitis B	0.00425	0.00425	CcSEcCtD
Palonosetron—Dysgeusia—Lamivudine—hepatitis B	0.00422	0.00422	CcSEcCtD
Palonosetron—Dizziness—Telbivudine—hepatitis B	0.00413	0.00413	CcSEcCtD
Palonosetron—Anaemia—Lamivudine—hepatitis B	0.00399	0.00399	CcSEcCtD
Palonosetron—Vomiting—Telbivudine—hepatitis B	0.00397	0.00397	CcSEcCtD
Palonosetron—Rash—Telbivudine—hepatitis B	0.00394	0.00394	CcSEcCtD
Palonosetron—Dermatitis—Telbivudine—hepatitis B	0.00394	0.00394	CcSEcCtD
Palonosetron—Headache—Telbivudine—hepatitis B	0.00391	0.00391	CcSEcCtD
Palonosetron—Convulsion—Lamivudine—hepatitis B	0.00374	0.00374	CcSEcCtD
Palonosetron—Nausea—Telbivudine—hepatitis B	0.00371	0.00371	CcSEcCtD
Palonosetron—Myalgia—Lamivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Palonosetron—Arthralgia—Lamivudine—hepatitis B	0.00367	0.00367	CcSEcCtD
Palonosetron—Anxiety—Lamivudine—hepatitis B	0.00366	0.00366	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00365	0.00365	CcSEcCtD
Palonosetron—Discomfort—Lamivudine—hepatitis B	0.00363	0.00363	CcSEcCtD
Palonosetron—Dry mouth—Lamivudine—hepatitis B	0.00359	0.00359	CcSEcCtD
Palonosetron—Anaphylactic shock—Lamivudine—hepatitis B	0.00352	0.00352	CcSEcCtD
Palonosetron—Infection—Lamivudine—hepatitis B	0.0035	0.0035	CcSEcCtD
Palonosetron—Shock—Lamivudine—hepatitis B	0.00346	0.00346	CcSEcCtD
Palonosetron—Nervous system disorder—Lamivudine—hepatitis B	0.00345	0.00345	CcSEcCtD
Palonosetron—Skin disorder—Lamivudine—hepatitis B	0.00342	0.00342	CcSEcCtD
Palonosetron—Anorexia—Lamivudine—hepatitis B	0.00336	0.00336	CcSEcCtD
Palonosetron—Hypotension—Lamivudine—hepatitis B	0.00329	0.00329	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Lamivudine—hepatitis B	0.00321	0.00321	CcSEcCtD
Palonosetron—Insomnia—Lamivudine—hepatitis B	0.00318	0.00318	CcSEcCtD
Palonosetron—Paraesthesia—Lamivudine—hepatitis B	0.00316	0.00316	CcSEcCtD
Palonosetron—Dyspnoea—Lamivudine—hepatitis B	0.00314	0.00314	CcSEcCtD
Palonosetron—Somnolence—Lamivudine—hepatitis B	0.00313	0.00313	CcSEcCtD
Palonosetron—Dyspepsia—Lamivudine—hepatitis B	0.0031	0.0031	CcSEcCtD
Palonosetron—Decreased appetite—Lamivudine—hepatitis B	0.00306	0.00306	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Palonosetron—Fatigue—Lamivudine—hepatitis B	0.00304	0.00304	CcSEcCtD
Palonosetron—Constipation—Lamivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Palonosetron—Pain—Lamivudine—hepatitis B	0.00301	0.00301	CcSEcCtD
Palonosetron—Gastrointestinal pain—Lamivudine—hepatitis B	0.00288	0.00288	CcSEcCtD
Palonosetron—Abdominal pain—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Palonosetron—Body temperature increased—Lamivudine—hepatitis B	0.00278	0.00278	CcSEcCtD
Palonosetron—Hypersensitivity—Lamivudine—hepatitis B	0.00259	0.00259	CcSEcCtD
Palonosetron—Asthenia—Lamivudine—hepatitis B	0.00253	0.00253	CcSEcCtD
Palonosetron—Pruritus—Lamivudine—hepatitis B	0.00249	0.00249	CcSEcCtD
Palonosetron—Diarrhoea—Lamivudine—hepatitis B	0.00241	0.00241	CcSEcCtD
Palonosetron—Dizziness—Lamivudine—hepatitis B	0.00233	0.00233	CcSEcCtD
Palonosetron—Vomiting—Lamivudine—hepatitis B	0.00224	0.00224	CcSEcCtD
Palonosetron—Rash—Lamivudine—hepatitis B	0.00222	0.00222	CcSEcCtD
Palonosetron—Dermatitis—Lamivudine—hepatitis B	0.00222	0.00222	CcSEcCtD
Palonosetron—Headache—Lamivudine—hepatitis B	0.00221	0.00221	CcSEcCtD
Palonosetron—Nausea—Lamivudine—hepatitis B	0.00209	0.00209	CcSEcCtD
